Deerfield Management Company, L.P. (Series C) Viatris Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Viatris Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 24,023,907 shares of VTRS stock, worth $248 Million. This represents 4.93% of its overall portfolio holdings.
Number of Shares
24,023,907
Previous 23,991,594
0.13%
Holding current value
$248 Million
Previous $209 Million
2.66%
% of portfolio
4.93%
Previous 5.29%
Shares
17 transactions
Others Institutions Holding VTRS
# of Institutions
1,138Shares Held
973MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$955 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$812 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$684 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$570 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...